These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22773299)

  • 21. 2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients.
    Cost C; Brock E; Adams-Huet B; Siegel JD; Ardura MI
    Pediatr Blood Cancer; 2011 Jan; 56(1):127-33. PubMed ID: 20973099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring of the h275y mutation in pandemic influenza A(H1N1) 2009 strains isolated in Malaysia.
    Suppiah J; Yusof MA; Othman KA; Saraswathy TS; Thayan R; Kasim FM; Murad S; Saat Z
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):100-4. PubMed ID: 21323171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemagglutinin and neuraminidase sequencing delineate nosocomial influenza outbreaks with accuracy equivalent to whole genome sequencing.
    Houghton R; Ellis J; Galiano M; Clark TW; Wyllie S
    J Infect; 2017 Apr; 74(4):377-384. PubMed ID: 28104386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.
    Wang B; Taylor J; Ratnamohan M; McPhie K; Kesson A; Dixit R; Booy R; Hurt A; Saksena N; Dwyer DE
    Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primarily oseltamivir-resistant influenza A (H1N1pdm09) virus evolving into a multidrug-resistant virus carrying H275Y and I223R neuraminidase substitutions.
    Grund S; Gkioule C; Termos T; Pfeifer N; Kobbe G; Verheyen J; Adams O
    Antivir Ther; 2015; 20(1):97-100. PubMed ID: 24941247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pandemic A/H1N1/2009 influenza in a paediatric haematology and oncology unit: successful management of a sudden outbreak.
    Buchbinder N; Dumesnil C; Pinquier D; Merle V; Filhon B; Schneider P; Vannier JP
    J Hosp Infect; 2011 Oct; 79(2):155-60. PubMed ID: 21783276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical characteristics and molecular epidemiology of the novel influenza A (H1N1) infection in children in Shanghai].
    Wang XS; Cai JH; Yao WL; Ge YL; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2013 May; 51(5):356-61. PubMed ID: 23941842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oseltamivir-resistant seasonal A(H1N1) and A(H1N1)pdm09 influenza viruses from the 2007/2008 to 2012/2013 season in Nara Prefecture, Japan.
    Yoneda M; Okayama A; Kitahori Y
    Jpn J Infect Dis; 2014; 67(5):385-8. PubMed ID: 25241691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
    Wong DD; Choy KT; Chan RW; Sia SF; Chiu HP; Cheung PP; Chan MC; Peiris JS; Yen HL
    J Virol; 2012 Oct; 86(19):10558-70. PubMed ID: 22811535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave.
    Fanella ST; Pinto MA; Bridger NA; Bullard JM; Coombs JM; Crockett ME; Olekson KL; Poliquin PG; Van Caeseele PG; Embree JE
    Infect Control Hosp Epidemiol; 2011 May; 32(5):435-43. PubMed ID: 21515973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.
    Hurt AC; Hardie K; Wilson NJ; Deng YM; Osbourn M; Leang SK; Lee RT; Iannello P; Gehrig N; Shaw R; Wark P; Caldwell N; Givney RC; Xue L; Maurer-Stroh S; Dwyer DE; Wang B; Smith DW; Levy A; Booy R; Dixit R; Merritt T; Kelso A; Dalton C; Durrheim D; Barr IG
    J Infect Dis; 2012 Jul; 206(2):148-57. PubMed ID: 22561367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy.
    Liu C; Schwartz BS; Vallabhaneni S; Nixon M; Chin-Hong PV; Miller SA; Chiu C; Damon L; Drew WL
    Emerg Infect Dis; 2010 Dec; 16(12):1910-7. PubMed ID: 21122221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
    Kawai N; Ikematsu H; Tanaka O; Matsuura S; Maeda T; Yamauchi S; Hirotsu N; Nishimura M; Iwaki N; Kashiwagi S
    J Infect Chemother; 2011 Jun; 17(3):375-81. PubMed ID: 21120678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
    Nguyen HT; Trujillo AA; Sheu TG; Levine M; Mishin VP; Shaw M; Ades EW; Klimov AI; Fry AM; Gubareva LV
    Antiviral Res; 2012 Mar; 93(3):381-6. PubMed ID: 22330888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
    Abed Y; Pizzorno A; Bouhy X; Boivin G
    Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit.
    Moore C; Galiano M; Lackenby A; Abdelrahman T; Barnes R; Evans MR; Fegan C; Froude S; Hastings M; Knapper S; Litt E; Price N; Salmon R; Temple M; Davies E
    J Infect Dis; 2011 Jan; 203(1):18-24. PubMed ID: 21148492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Influenza Infection Among Adult and Pediatric Populations With Hematologic Malignancy and Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis.
    Atalla E; Kalligeros M; Mylona EK; Tsikala-Vafea M; Shehadeh F; Georgakas J; Mylonakis E
    Clin Ther; 2021 May; 43(5):e66-e85. PubMed ID: 33812700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010.
    Malato L; Llavador V; Marmier E; Youssef J; Balick Weber C; Rozé H; Bessede E; Fleury HJ
    Euro Surveill; 2011 Jan; 16(4):. PubMed ID: 21284922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel influenza a (H1N1) infection in a Pediatric Hematology Oncology Clinic during the 2009-2010 pandemia.
    Ozdemir N; Celkan T; Midilli K; Aygün G; Sinekbasan S; Kılıç O; Apak H; Camcıoğlu Y; Yıldız I
    Pediatr Hematol Oncol; 2011 May; 28(4):288-93. PubMed ID: 21413832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.